Clinical Trials Logo
  1. Home
  2. Calciphylaxis
  3. NCT02790073

Phase 2 Study With SNF472 in Calciphylaxis Patients

Calciphylaxis Clinical Trial

Official title:
Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients

Clinical Trial Summary

To evaluate the effect of SNF472 on top of standard of care on promoting wound healing and other parameters of therapeutic response in haemodialysis patients with calciphylaxis (calcific uraemic arteriolopathy, CUA).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02790073
Study type Interventional
Source Laboratoris Sanifit
Contact
Status Completed
Phase Phase 2
Start date May 2016
Completion date November 15, 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT01578382 - Pathophysiology of Martorell Hypertensive Ischemic Leg Ulcer (HYTILU)
Active, not recruiting NCT04592640 - Stem Cells for Uremic Calciphylaxis Patients N/A
Terminated NCT03319914 - Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate
Recruiting NCT06065852 - National Registry of Rare Kidney Diseases
Terminated NCT03150420 - A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients Phase 3
Recruiting NCT03146793 - The Early Administration of Sodium Thiosulfate Should Help to Reduce the Mortality of Dialysis Patients With Calciphylaxis, From a National Cohort N/A
Completed NCT02278692 - Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy N/A
Completed NCT02854046 - Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and Outcome
Terminated NCT02527213 - Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopath Phase 3
Recruiting NCT03032835 - Partners Calciphylaxis Biobank
Completed NCT01289626 - Efficacy of Lanthanum Carbonate in Calciphylaxis Phase 1
Recruiting NCT06283589 - The SEAPORT 1 Study: Evaluation of the Safety and Tolerability of INZ-701 in Adults With End-Stage Kidney Disease Undergoing Hemodialysis Phase 1
Completed NCT04195906 - Phase 3 Study of SNF472 for Calciphylaxis Phase 3
Recruiting NCT02635373 - European Calciphylaxis Registry Network N/A
Recruiting NCT05018221 - Better Evidence and Translation for Calciphylaxis Phase 3